{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:42:55Z","timestamp":1792165375211,"version":"4.4.0"},"reference-count":201,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcf.2026.03.021","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T10:49:37Z","timestamp":1775386177000},"page":"393-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Research updates in cystic fibrosis related diabetes: Understanding pathophysiology, expanding animal and human islet models, and advancing clinical and translational research"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-8954","authenticated-orcid":false,"given":"Melissa S.","family":"Putman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Hull-Meichle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafagh A.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7191-5538","authenticated-orcid":false,"given":"Katherine","family":"Tuggle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6810-5587","authenticated-orcid":false,"given":"Paula","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2885-3382","authenticated-orcid":false,"given":"Lee A.","family":"Borthwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob G.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.Danielle","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0253-2663","authenticated-orcid":false,"given":"Sarah A.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-8428","authenticated-orcid":false,"given":"Xingshen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2389-9277","authenticated-orcid":false,"given":"John F.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsing","family":"Leir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6467-5029","authenticated-orcid":false,"given":"Lena","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibi Uhre","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4654-0569","authenticated-orcid":false,"given":"Darko","family":"Stefanovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte K.","family":"Boughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1724-9868","authenticated-orcid":false,"given":"Andrea","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9909-6724","authenticated-orcid":false,"given":"Amir","family":"Moheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2893-3211","authenticated-orcid":false,"given":"James A.M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.03.021_bib0001","first-page":"753","article-title":"Das Coeliakiesyndrom bei angeborener zystischer Pankreasfibromatose und Bronchiekatasien","author":"Fanconi","year":"1936","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"10.1016\/j.jcf.2026.03.021_bib0002","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic fibrosis of the pancreas and its relation to celiac disease - a clinical and pathological study","volume":"56","author":"Andersen","year":"1938","journal-title":"Am J Dis Child"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17404-z","article-title":"Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes","volume":"7","author":"Bogdani","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00718598","article-title":"Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study","volume":"414","author":"Lohr","year":"1989","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0005","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/clinem\/dgz209","article-title":"In situ analysis reveals that CFTR is expressed in only a small minority of beta-cells in normal adult Human pancreas","volume":"105","author":"White","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00125-025-06559-4","article-title":"Generation of a pseudo-timeline describing progressive human exocrine and endocrine pancreatic pathology in cystic fibrosis through novel semi-quantitative scoring and AI-driven quantitative image analysis","volume":"69","author":"Al-Selwi","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcf.2026.03.021_bib0007","series-title":"Pancreatic cancer and tumor microenvironment","author":"Phillips","year":"2012"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0008","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI30082","article-title":"The pancreatic stellate cell: a star on the rise in pancreatic diseases","volume":"117","author":"Omary","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0009","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s007950000020","article-title":"Pathogenesis and progression of human pancreatic fibrosis","volume":"33","author":"Suda","year":"2000","journal-title":"Med Electron Microsc"},{"key":"10.1016\/j.jcf.2026.03.021_bib0010","article-title":"Single cell and spatial characterization of the human pancreas reveals drivers of beta cell dysfunction in cystic fibrosis","volume":"16","author":"Mummey","year":"2025","journal-title":"bioRxiv [Preprint]"},{"key":"10.1016\/j.jcf.2026.03.021_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103791","article-title":"Pancreatic stellate cells have adipogenic and fibrogenic potentials but only show increased pro-fibrogenic propensity upon aging","volume":"86","author":"Soultoukis","year":"2025","journal-title":"Redox Biol"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0012","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00125-026-06678-6","article-title":"The emerging role of pancreatic exocrine fibrosis as a common aetiological driver of islet dysfunction and diabetes: opportunities for novel disease-modifying interventions","volume":"69","author":"Kattner","year":"2026","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0013","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0046-8177(84)80191-4","article-title":"Endocrine pancreas in cystic fibrosis: an immunohistochemical study","volume":"15","author":"Iannucci","year":"1984","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0014","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/15513818609025923","article-title":"Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies","volume":"6","author":"Soejima","year":"1986","journal-title":"Pediatr Pathol"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.021_bib0015","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98240","article-title":"Cystic fibrosis-related diabetes is caused by islet loss and inflammation","volume":"3","author":"Hart","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0016","first-page":"1267","article-title":"Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis","volume":"81","author":"Couce","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0017","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc17-1387","article-title":"Islet interleukin-1beta immunoreactivity is an early feature of cystic fibrosis that may contribute to beta-cell failure","volume":"41","author":"Hull","year":"2018","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.021_bib0018","first-page":"602","article-title":"Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study","volume":"110","author":"Abdul-Karim","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jcf.2026.03.021_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1269139","article-title":"Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes","volume":"14","author":"Malik","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/er.2009-0035","article-title":"The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action","volume":"31","author":"Richards","year":"2010","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0021","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00125-017-4272-9","article-title":"The islet endothelial cell: a novel contributor to beta cell secretory dysfunction in diabetes","volume":"60","author":"Hogan","year":"2017","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.021_bib0022","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1007\/s00125-020-05186-5","article-title":"Beta cell dysfunction in diabetes: the islet microenvironment as an unusual suspect","volume":"63","author":"Almaca","year":"2020","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/db13-0617","article-title":"The beta-cell\/EC axis: how do islet cells talk to each other?","volume":"63","author":"Peiris","year":"2014","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0024","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/j.2040-4603.2019.tb00068.x","article-title":"Pancreatic blood flow with special emphasis on blood perfusion of the islets of Langerhans","volume":"9","author":"Jansson","year":"2019","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jcf.2026.03.021_bib0025","doi-asserted-by":"crossref","unstructured":"Castillo JJ, Aplin AC, Akter R, Hull-Meichle RL. 13-OR: Cystic fibrosis donors exhibit striking decrease in pancreatic islet and exocrine capillaries. Diabetes. 2022;71(Suppl 1):13-OR.","DOI":"10.2337\/db22-13-OR"},{"key":"10.1016\/j.jcf.2026.03.021_bib0026","doi-asserted-by":"crossref","DOI":"10.1172\/JCI60016","article-title":"Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover","volume":"122","author":"Unger","year":"2012","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0027","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJM197007162830301","article-title":"Abnormal alpha-cell function in diabetes","volume":"283","author":"M\u00fcller","year":"1970","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0028","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2337\/diab.33.3.277","article-title":"Elevated pancreatic glucagon in obesity","volume":"33","author":"Starke","year":"1984","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.021_bib0029","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/db23-0056","article-title":"Glucose controls glucagon secretion by regulating fatty acid oxidation in pancreatic alpha cells","volume":"72","author":"Armour","year":"2023","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.jcf.2026.03.021_bib0030","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/j.celrep.2018.05.035","article-title":"CPT1a-Dependent long-chain fatty acid oxidation contributes to maintaining glucagon secretion from pancreatic islets","volume":"23","author":"Briant","year":"2018","journal-title":"Cell Rep"},{"issue":"21","key":"10.1016\/j.jcf.2026.03.021_bib0031","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1113\/JP279775","article-title":"Resistance is futile?\u2019 \u2013 paradoxical inhibitory effects of KATP channel closure in glucagon-secreting \u03b1-cells","volume":"598","author":"Zhang","year":"2020","journal-title":"J. Physiol. (Lond.)"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0032","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cmet.2013.10.014","article-title":"Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.jcf.2026.03.021_bib0033","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1096\/fj.14-265918","article-title":"Submembrane ATP and Ca2+ kinetics in alpha-cells: unexpected signaling for glucagon secretion","volume":"29","author":"Li","year":"2015","journal-title":"FASEB J"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.021_bib0034","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s00125-019-4857-6","article-title":"Glucose controls glucagon secretion by directly modulating cAMP in alpha cells","volume":"62","author":"Yu","year":"2019","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.021_bib0035","doi-asserted-by":"crossref","first-page":"E1107","DOI":"10.1152\/ajpendo.00207.2012","article-title":"SSTR2 is the functionally dominant somatostatin receptor in human pancreatic \u03b2- and \u03b1-cells","volume":"303","author":"Kailey","year":"2012","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0036","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41467-018-08193-8","article-title":"Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion","volume":"10","author":"Vergari","year":"2019","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0037","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cmet.2009.02.007","article-title":"Insulin signaling in \u03b1 cells modulates glucagon secretion In vivo","volume":"9","author":"Kawamori","year":"2009","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0038","doi-asserted-by":"crossref","first-page":"E130","DOI":"10.1152\/ajpendo.00344.2014","article-title":"Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic \u03b1-cell by lowering cAMP","volume":"308","author":"Elliott","year":"2015","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0039","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0081","article-title":"Knudsen J.G Metabolic regulation of glucagon secretion","volume":"259","author":"Armour","year":"2023","journal-title":"J Endocrinol"},{"issue":"51","key":"10.1016\/j.jcf.2026.03.021_bib0040","doi-asserted-by":"crossref","first-page":"33905","DOI":"10.1074\/jbc.273.51.33905","article-title":"The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in beta cells but not in alpha cells and are also observed in human islets","volume":"273","author":"Detimary","year":"1998","journal-title":"J Biol Chem"},{"issue":"30","key":"10.1016\/j.jcf.2026.03.021_bib0041","doi-asserted-by":"crossref","first-page":"18572","DOI":"10.1074\/jbc.272.30.18572","article-title":"Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells","volume":"272","author":"Schuit","year":"1997","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0042","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1371\/journal.pbio.0050143","article-title":"A KATP channel-dependent pathway within \u03b1 cells regulates glucagon release from both rodent and Human islets of langerhans","volume":"5","author":"MacDonald","year":"2007","journal-title":"PLoS Biol."},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0043","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/me.2014-1321","article-title":"TASK-1 potassium channels limit pancreatic \u03b1-cell calcium influx and glucagon secretion","volume":"29","author":"Dadi","year":"2015","journal-title":"Mol Endocrinol"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0044","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41598-017-00098-8","article-title":"CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells","volume":"7","author":"Edlund","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.021_bib0045","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2337\/dc15-1643","article-title":"Evaluation of efficacy and safety of the glucagon receptor antagonist LY2409021 in patients with type 2 diabetes: 12- and 24-week phase 2 studies","volume":"39","author":"Kazda","year":"2016","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0046","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.celrep.2018.10.018","article-title":"Insulin secretion depends on intra-islet glucagon signaling","volume":"25","author":"Svendsen","year":"2018","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0047","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00125-020-05096-6","article-title":"Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis","volume":"63","author":"Aitken","year":"2020","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0048","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-3476(05)80032-0","article-title":"Pancreatic endocrine function in cystic fibrosis","volume":"118","author":"Moran","year":"1991","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0049","first-page":"207","article-title":"Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance","volume":"128","author":"Lanng","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.jcf.2026.03.021_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1249876","article-title":"Characterization of impaired beta and alpha cell function in response to an oral glucose challenge in cystic fibrosis: a cross-sectional study","volume":"14","author":"Nielsen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0052","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2337\/dbi19-0021","article-title":"A primary role for alpha-cells as amino acid sensors","volume":"69","author":"Dean","year":"2020","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.021_bib0053","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s00125-023-05947-y","article-title":"100 years of glucagon and 100 more","volume":"66","author":"Wewer Albrechtsen","year":"2023","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0054","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.cmet.2017.05.011","article-title":"Interrupted glucagon signaling reveals hepatic alpha cell axis and role for l-glutamine in alpha cell proliferation","volume":"25","author":"Dean","year":"2017","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12020-007-9026-x","article-title":"Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas","volume":"32","author":"Boom","year":"2007","journal-title":"Endocrine"},{"issue":"11","key":"10.1016\/j.jcf.2026.03.021_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111792","article-title":"Restoring glutamate receptor signaling in pancreatic alpha cells rescues glucagon responses in type 1 diabetes","volume":"41","author":"Panzer","year":"2022","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0058","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajpath.2020.10.017","article-title":"Animal and cell culture models for cystic fibrosis: which model is right for your application?","volume":"191","author":"McCarron","year":"2021","journal-title":"Am J Pathol"},{"issue":"2S","key":"10.1016\/j.jcf.2026.03.021_bib0059","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jcf.2017.09.001","article-title":"Animal and model systems for studying cystic fibrosis","volume":"17","author":"Rosen","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"5191","key":"10.1016\/j.jcf.2026.03.021_bib0060","first-page":"1705","article-title":"Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR","volume":"266","author":"Zhou","year":"1994","journal-title":"Science (1979)"},{"key":"10.1016\/j.jcf.2026.03.021_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.630654","article-title":"CFTR deficiency affects glucose homeostasis via regulating GLUT4 plasma membrane transportation","volume":"9","author":"Gu","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"21","key":"10.1016\/j.jcf.2026.03.021_bib0062","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1128\/MCB.25.21.9713-9723.2005","article-title":"Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism","volume":"25","author":"Kim","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.021_bib0063","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/db05-1647","article-title":"Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury","volume":"55","author":"Stalvey","year":"2006","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.jcf.2026.03.021_bib0064","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.2337\/db14-0810","article-title":"The \u0394F508 mutation in the Cystic Fibrosis transmembrane conductance regulator is associated with progressive insulin resistance and decreased functional \u03b2-cell mass in mice","volume":"64","author":"Font\u00e9s","year":"2015","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0065","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jcf.2021.05.006","article-title":"VIP reduction in the pancreas of F508del homozygous CF mice and early signs of Cystic Fibrosis related diabetes (CFRD)","volume":"20","author":"Semaniakou","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0066","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1530\/JOE-18-0570","article-title":"Defective exocytosis and processing of insulin in a cystic fibrosis mouse model","volume":"241","author":"Edlund","year":"2019","journal-title":"J Endocrinol"},{"issue":"19","key":"10.1016\/j.jcf.2026.03.021_bib0067","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123529","article-title":"A sheep model of cystic fibrosis generated by CRISPR\/Cas9 disruption of the CFTR gene","volume":"3","author":"Fan","year":"2018","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.021_bib0068","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1096\/fba.2021-00043","article-title":"Sheep models of F508del and G542X cystic fibrosis mutations show cellular responses to human therapeutics","volume":"3","author":"Viotti Perisse","year":"2021","journal-title":"FASEB Bioadv"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0069","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1096\/fba.2022-00085","article-title":"Early developmental phenotypes in the cystic fibrosis sheep model","volume":"5","author":"Van Wettere","year":"2023","journal-title":"FASEB Bioadv"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s10020-024-00871-2","article-title":"Stellate cells are in utero markers of pancreatic disease in cystic fibrosis","volume":"30","author":"Leir","year":"2024","journal-title":"Mol Med"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.021_bib0071","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI43052","article-title":"Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis","volume":"120","author":"Sun","year":"2010","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0072","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ajpath.2014.01.035","article-title":"Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets","volume":"184","author":"Sun","year":"2014","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0073","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1210\/en.2015-1935","article-title":"A transient metabolic recovery from early life glucose intolerance in cystic fibrosis ferrets occurs during pancreatic remodeling","volume":"157","author":"Yi","year":"2016","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0074","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ajpath.2017.12.015","article-title":"Pancreatic and islet remodeling in Cystic fibrosis transmembrane conductance regulator (CFTR) knockout ferrets","volume":"188","author":"Rotti","year":"2018","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.021_bib0075","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1172\/JCI60610","article-title":"Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets","volume":"122","author":"Olivier","year":"2012","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.021_bib0076","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/en.2017-00187","article-title":"CFTR influences beta cell function and insulin secretion through non-cell autonomous exocrine-derived factors","volume":"158","author":"Sun","year":"2017","journal-title":"Endocrinology"},{"issue":"15\u201316","key":"10.1016\/j.jcf.2026.03.021_bib0077","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/hum.2024.215","article-title":"Novel cystic fibrosis ferret model enables visualization of CFTR expression cells and genetic CFTR reactivation","volume":"36","author":"Yuan","year":"2025","journal-title":"Hum Gene Ther"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.021_bib0078","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1164\/rccm.201512-2518OC","article-title":"Abnormal glucose tolerance in infants and young children with cystic fibrosis","volume":"194","author":"Yi","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.jcf.2026.03.021_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111393","article-title":"CFTR represses a PDX1 axis to govern pancreatic ductal cell fate","volume":"27","author":"Rotti","year":"2024","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcf.2021.04.010","article-title":"Lack of CFTR alters the ferret pancreatic ductal epithelial secretome and cellular proteome: implications for exocrine\/endocrine signaling","volume":"21","author":"Rotti","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"485","key":"10.1016\/j.jcf.2026.03.021_bib0081","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7531","article-title":"In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis","volume":"11","author":"Sun","year":"2019","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.021_bib0082","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157229","article-title":"In utero and postnatal ivacaftor\/lumacaftor therapy rescues multiorgan disease in CFTR-F508del ferrets","volume":"9","author":"Evans","year":"2024","journal-title":"JCI Insight"},{"issue":"7980","key":"10.1016\/j.jcf.2026.03.021_bib0083","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41586-023-06549-9","article-title":"Transgenic ferret models define pulmonary ionocyte diversity and function","volume":"621","author":"Yuan","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0084","first-page":"1971","article-title":"Highly efficient transgenesis in ferrets using CRISPR\/Cas9-mediated homology-independent insertion at the ROSA26","volume":"9","author":"Yu","year":"2019","journal-title":"Locus. Sci Rep."},{"issue":"19\u201320","key":"10.1016\/j.jcf.2026.03.021_bib0085","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/hum.2022.036","article-title":"Recombinant Adeno-associated virus-mediated editing of the G551D Cystic fibrosis transmembrane conductance regulator mutation in Ferret airway basal cells","volume":"33","author":"Yan","year":"2022","journal-title":"Hum Gene Ther"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.021_bib0086","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1164\/rccm.202505-1242OC","article-title":"Ionocyte CFTR coordinates chloride absorption and secretion to balance airway fluid","volume":"211","author":"Yuan","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2026.03.021_bib0087","unstructured":"Congress.gov. S.5002 - FDA Modernization Act 2.0. Accessed April 1, 2026. https:\/\/www.congress.gov\/bill\/117th-congress\/senate-bill\/5002;Pages."},{"key":"10.1016\/j.jcf.2026.03.021_bib0088","unstructured":"Congress.gov. H.R.7248 - Continuing Systems of Care for Children Act. Accessed April 1, 2026. https:\/\/www.congress.gov\/bill\/118th-congress\/house-bill\/7248;Pages."},{"key":"10.1016\/j.jcf.2026.03.021_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119741","article-title":"Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testing","volume":"233","author":"Mastikhina","year":"2020","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0090","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcf.2021.10.004","article-title":"Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip","volume":"21","author":"Plebani","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.021_bib0091","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073038","article-title":"Dressed in collagen: 2D and 3D cardiac fibrosis models","volume":"26","author":"Cardona-Timoner","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0092","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.tibtech.2019.12.010","article-title":"Bioengineered 3D models to recapitulate tissue fibrosis","volume":"38","author":"Sacchi","year":"2020","journal-title":"Trends Biotechnol"},{"issue":"19","key":"10.1016\/j.jcf.2026.03.021_bib0093","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911642","article-title":"Multicellular 3D models for the study of cardiac fibrosis","volume":"23","author":"Picchio","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.021_bib0094","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s42255-022-00607-8","article-title":"Every islet matters: improving the impact of human islet research","volume":"4","author":"Gloyn","year":"2022","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cmet.2024.09.001","article-title":"HumanIslets.Com: improving accessibility, integration, and usability of human research islet data","volume":"37","author":"Ewald","year":"2025","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcf.2026.03.021_bib0096","first-page":"205","article-title":"Generating Human pancreatic tissue slices to study endocrine and exocrine pancreas physiology","author":"Panzer","year":"2024","journal-title":"J Vis Exp"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0097","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jcf.2025.04.006","article-title":"The role of islet CFTR in the development of cystic fibrosis-related diabetes: a semi-systematic review","volume":"24","author":"Engstr\u00f6m","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.021_bib0098","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1172\/JCI58447","article-title":"A genetically engineered human pancreatic \u03b2 cell line exhibiting glucose-inducible insulin secretion","volume":"121","author":"Ravassard","year":"2011","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0099","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.cmet.2020.04.005","article-title":"Patch-seq links single-cell transcriptomes to Human islet dysfunction in diabetes","volume":"31","author":"Camunas-Soler","year":"2020","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0100","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/db20-1115","article-title":"Pancreatic pseudoislets: an organoid archetype for metabolism research","volume":"70","author":"Friedlander","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.jcf.2026.03.021_bib0101","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.642152","article-title":"Human pluripotent stem cells to model islet defects in diabetes","volume":"12","author":"Balboa","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.021_bib0102","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/db25-0037","article-title":"Advances in cell replacement therapies for diabetes","volume":"74","author":"Hering","year":"2025","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.jcf.2026.03.021_bib0103","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1016\/j.celrep.2019.11.019","article-title":"Modeling progressive fibrosis with pluripotent stem cells identifies an anti-fibrotic small molecule","volume":"29","author":"Vijayaraj","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcf.2026.03.021_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102420","article-title":"Cardiac fibrosis models using human induced pluripotent stem cell-derived cardiac tissues allow anti-fibrotic drug screening in vitro","volume":"54","author":"Iseoka","year":"2021","journal-title":"Stem Cell Res"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0105","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.119.315491","article-title":"Generation of quiescent cardiac fibroblasts from Human induced pluripotent stem cells for In vitro modeling of cardiac fibrosis","volume":"125","author":"Zhang","year":"2019","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcf.2018.03.013","article-title":"The CF Canada-Sick Kids Program in individual CF therapy: a resource for the advancement of personalized medicine in CF","volume":"18","author":"Eckford","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0107","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1038\/s41467-022-31854-8","article-title":"A multimodal iPSC platform for cystic fibrosis drug testing","volume":"13","author":"Berical","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0108","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/2050640616670565","article-title":"Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis","volume":"5","author":"Hohwieler","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jcf.2026.03.021_bib0109","first-page":"S190","article-title":"Investigating the potential effects of CFTR mutations on pancreatic lineage commitment to elucidate the developmental origins of CFRD","volume":"24","author":"Cho","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.03.021_bib0110","first-page":"S186","article-title":"Understanding the role of CFTR in pancreatic progenitor development to target exocrine pancreatic insufficiency","volume":"24","author":"Ryan","year":"2025","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0111","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jcf.2022.11.007","article-title":"Patient-derived cell models for personalized medicine approaches in cystic fibrosis","volume":"22","author":"Ramalho","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0112","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/s42003-024-07193-3","article-title":"Exploring human pancreatic organoid modelling through single-cell RNA sequencing analysis","volume":"7","author":"Cherubini","year":"2024","journal-title":"Commun Biol"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0113","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00018-022-04287-1","article-title":"Impaired regulation of PMCA activity by defective CFTR expression promotes epithelial cell damage in alcoholic pancreatitis and hepatitis","volume":"79","author":"Madacsy","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.021_bib0114","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00018-023-04836-2","article-title":"Human pancreatic ductal organoids with controlled polarity provide a novel ex vivo tool to study epithelial cell physiology","volume":"80","author":"Varga","year":"2023","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0115","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.stemcr.2018.02.005","article-title":"Expansion of adult Human pancreatic tissue yields organoids harboring progenitor cells with endocrine differentiation potential","volume":"10","author":"Loomans","year":"2018","journal-title":"Stem Cell Rep"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.021_bib0116","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0117","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1038\/s41467-019-11178-w","article-title":"Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders","volume":"10","author":"Shik Mun","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.03.021_bib0118","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coph.2019.10.004","article-title":"Implementation of pre-clinical methodologies to study fibrosis and test anti-fibrotic therapy","volume":"49","author":"Oakley","year":"2019","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0119","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2337\/dbi20-0018","article-title":"Bridging the gap: pancreas tissue slices from organ and tissue donors for the study of diabetes pathogenesis","volume":"73","author":"Cohrs","year":"2024","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0120","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.30651","article-title":"A bioreactor technology for modeling fibrosis in Human and rodent precision-cut liver slices","volume":"70","author":"Paish","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0121","doi-asserted-by":"crossref","first-page":"L896","DOI":"10.1152\/ajplung.00084.2017","article-title":"An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices","volume":"312","author":"Alsafadi","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jcf.2026.03.021_bib0122","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.trsl.2015.11.007","article-title":"Precision-cut human kidney slices as a model to elucidate the process of renal fibrosis","volume":"170","author":"Stribos","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.jcf.2026.03.021_bib0123","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tiv.2016.05.012","article-title":"Human precision-cut liver slices as a model to test antifibrotic drugs in the early onset of liver fibrosis","volume":"35","author":"Westra","year":"2016","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0124","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12967-025-06313-9","article-title":"Protective role of oleic acid against palmitic acid-induced pancreatic fibrosis","volume":"23","author":"Frendi","year":"2025","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0125","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/ehf2.13832","article-title":"Mechanosensitive molecular mechanisms of myocardial fibrosis in living myocardial slices","volume":"9","author":"Nunez-Toldra","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102399","article-title":"Protocol to generate and utilize pancreatic tissue slices to study endocrine and exocrine physiology in situ from mouse and human tissue","volume":"4","author":"Panzer","year":"2023","journal-title":"STAR Protoc"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0127","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114346","article-title":"Impaired islet function and normal exocrine enzyme secretion occur with low inter-regional variation in type 1 diabetes","volume":"43","author":"Drotar","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcf.2026.03.021_bib0128","article-title":"Functional characterization of the Human islet microvasculature using living pancreas slices","volume":"11","author":"Mateus Goncalves","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0129","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1038\/s41467-020-17040-8","article-title":"Long-term culture of human pancreatic slices as a model to study real-time islet regeneration","volume":"11","author":"Qadir","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcmgh.2023.05.010","article-title":"In Vivo and In vitro models to study liver fibrosis: mechanisms and limitations","volume":"16","author":"Lee","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol."},{"issue":"171","key":"10.1016\/j.jcf.2026.03.021_bib0131","doi-asserted-by":"crossref","first-page":"230127","DOI":"10.1183\/16000617.0127-2023","article-title":"The evolution of in vitro models of lung fibrosis: promising prospects for drug discovery","volume":"33","author":"Kolanko","year":"2024","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0132","doi-asserted-by":"crossref","first-page":"e1793","DOI":"10.1210\/clinem\/dgaa932","article-title":"Glucose tolerance stages in cystic fibrosis are identified by a unique pattern of defects of beta-cell function","volume":"106","author":"Piona","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0133","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-10-1003","article-title":"Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients","volume":"165","author":"Battezzati","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0134","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/db16-0394","article-title":"Reduced beta-cell secretory capacity in pancreatic-insufficient, but not pancreatic-sufficient, cystic fibrosis despite normal glucose tolerance","volume":"66","author":"Sheikh","year":"2017","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.021_bib0135","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/pedi.12700","article-title":"beta-cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose >\/=155 mg\/dL","volume":"19","author":"Nyirjesy","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0136","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2265.1994.tb02533.x","article-title":"Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance","volume":"41","author":"Lanng","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.021_bib0137","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/diab.43.8.1020","article-title":"Insulin sensitivity in cystic fibrosis","volume":"43","author":"Moran","year":"1994","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0138","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/diabetes.50.1.150","article-title":"Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity","volume":"50","author":"Breda","year":"2001","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0139","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1109\/10.995680","article-title":"The oral glucose minimal model: estimation of insulin sensitivity from a meal test","volume":"49","author":"Dalla Man","year":"2002","journal-title":"IEEE Trans Biomed Eng"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2337\/diabetes.49.3.373","article-title":"Accurate measurement of endogenous insulin secretion does not require separate assessment of C-peptide kinetics","volume":"49","author":"Watanabe","year":"2000","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2026.03.021_bib0141","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jcf.2019.08.004","article-title":"Hypoglycemia in cystic fibrosis: prevalence, impact and treatment","volume":"18","author":"Moheet","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.021_bib0142","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00125-024-06220-6","article-title":"Insulin sensitivity, disposition index and insulin clearance in cystic fibrosis: a cross-sectional study","volume":"67","author":"Nielsen","year":"2024","journal-title":"Diabetologia"},{"issue":"176","key":"10.1016\/j.jcf.2026.03.021_bib0143","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0220-2024","article-title":"20 years of the Montreal Cystic Fibrosis related Diabetes Screening Cohort: key insights","volume":"34","author":"Alexandre-Heymann","year":"2025","journal-title":"Eur Respir Rev"},{"issue":"10","key":"10.1016\/j.jcf.2026.03.021_bib0144","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/clinem\/dgaa448","article-title":"Hypoglycemia and islet dysfunction following oral glucose tolerance testing in pancreatic-insufficient cystic fibrosis","volume":"105","author":"Kilberg","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0145","first-page":"E667","article-title":"Quantitative estimation of insulin sensitivity","volume":"236","author":"Bergman","year":"1979","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0146","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/152091503322641060","article-title":"MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test","volume":"5","author":"Boston","year":"2003","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0147","doi-asserted-by":"crossref","first-page":"e1108","DOI":"10.1210\/clinem\/dgae308","article-title":"Estimation of glucose absorption, insulin sensitivity, and glucose effectiveness from the oral glucose tolerance test","volume":"110","author":"Stefanovski","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0148","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/oby.23653","article-title":"Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum","volume":"31","author":"Fiorentino","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jcf.2026.03.021_bib0149","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5636499","article-title":"Regulation of glucose insulinotropic peptide and intestinal glucose transporters in the diet-induced obese mouse","volume":"2022","author":"Rhodes","year":"2022","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2337\/db15-0893","article-title":"The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 Diabetes: a randomized controlled trial","volume":"65","author":"Thazhath","year":"2016","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0151","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2337\/db21-0077","article-title":"Human islet MicroRNA-200c is elevated in type 2 diabetes and targets the transcription factor ETV5 to reduce insulin secretion","volume":"71","author":"Ofori","year":"2022","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0152","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00125-025-06645-7","article-title":"Dynamic changes in circulating microRNAs during oral glucose tolerance testing support their potential as diagnostic and monitoring biomarkers in cystic fibrosis-related diabetes","volume":"69","author":"Westholm","year":"2026","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0153","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/dom.13027","article-title":"Exosomes as new players in metabolic organ cross-talk","volume":"19","author":"Guay","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0154","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41392-020-00258-9","article-title":"Application of exosomes as liquid biopsy in clinical diagnosis","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jcf.2026.03.021_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jprot.2018.07.001","article-title":"Comparative proteomics of respiratory exosomes in cystic fibrosis, primary ciliary dyskinesia and asthma","volume":"185","author":"Rollet-Cohen","year":"2018","journal-title":"J Proteomics"},{"issue":"11","key":"10.1016\/j.jcf.2026.03.021_bib0156","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2337\/db17-1308","article-title":"Altered extracellular vesicle concentration, cargo, and function in diabetes","volume":"67","author":"Freeman","year":"2018","journal-title":"Diabetes"},{"issue":"7014","key":"10.1016\/j.jcf.2026.03.021_bib0157","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature03076","article-title":"A pancreatic islet-specific microRNA regulates insulin secretion","volume":"432","author":"Poy","year":"2004","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0158","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/hep.30156","article-title":"MicroRNA sequencing identifies a serum MicroRNA panel, which combined with aspartate aminotransferase to platelet ratio index can detect and monitor liver disease in pediatric cystic fibrosis","volume":"68","author":"Calvopina","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0159","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13105-021-00860-7","article-title":"The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications","volume":"78","author":"Teimouri","year":"2022","journal-title":"J Physiol Biochem"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0160","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00125-012-2820-x","article-title":"14-3-3 proteins are essential signalling hubs for beta cell survival","volume":"56","author":"Lim","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055396","article-title":"The oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitus","volume":"8","author":"Oggianu","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0162","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jcf.2024.06.004","article-title":"Beyond insulin: unraveling the complex interplay of ER stress, oxidative damage, and CFTR modulation in CFRD","volume":"23","author":"Umashankar","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.021_bib0163","article-title":"Cystic fibrosis related liver disease and endocrine considerations","volume":"27","author":"Sherwood","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.021_bib0164","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1002\/ppul.26562","article-title":"Changes in glucose tolerance in people with cystic fibrosis after initiation of first-generation CFTR modulator treatment","volume":"58","author":"Ekblond","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0165","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jcf.2023.01.004","article-title":"Improved glucose tolerance after initiation of Elexacaftor \/Tezacaftor \/ Ivacaftor in adults with cystic fibrosis","volume":"22","author":"Steinack","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0166","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ppul.1142","article-title":"Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis","volume":"32","author":"Koch","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.021_bib0167","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.jcf.2026.03.021_bib0168","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1164\/rccm.202104-1060LE","article-title":"Cystic fibrosis-related diabetes is associated with worse lung function trajectory despite ivacaftor use","volume":"204","author":"Bengtson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2026.03.021_bib0169","unstructured":"James Lind Alliance. Cystic Fibrosis Research Priorities Refresh. Accessed April 1, 2026. https:\/\/www.jla.nihr.ac.uk\/priority-setting-partnerships\/cystic-fibrosis-refresh."},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.201808-1501ED","article-title":"Is cystic fibrosis-related diabetes reversible? New data on CFTR potentiation and insulin secretion","volume":"199","author":"Norris","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0171","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jcf.2019.03.009","article-title":"An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB)","volume":"18","author":"Rosenfeld","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0172","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1164\/rccm.202008-3177OC","article-title":"Ivacaftor in infants aged 4 to <12 months with cystic fibrosis and a gating mutation. Results of a two-part phase 3 clinical trial","volume":"203","author":"Davies","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0173","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcf.2019.05.015","article-title":"Disease progression in patients with cystic fibrosis treated with ivacaftor: data from national US and UK registries","volume":"19","author":"Volkova","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0174","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2021.09.001","article-title":"The effect of elexacaftor\/tezacaftor\/ivacaftor (ETI) on glycemia in adults with cystic fibrosis","volume":"21","author":"Scully","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jcf.2023.11.005","article-title":"Decline in HbA1c during the first year of elexacaftor\/tezacaftor\/ivacaftor treatment in the Danish cystic fibrosis cohort: short title: decline in HbA1c after elexacaftor\/tezacaftor\/ivacaftor treatment","volume":"23","author":"Nielsen","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.021_bib0176","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1210\/clinem\/dgae857","article-title":"Glycemia and insulin secretion in cystic fibrosis two years after elexacaftor\/tezacaftor\/ivacaftor PROMISE-ENDO","volume":"110","author":"Chan","year":"2024","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0177","doi-asserted-by":"crossref","first-page":"e636","DOI":"10.1210\/clinem\/dgaf165","article-title":"Elucidating the impact of elexacaftor\/tezacaftor\/ivacaftor on glucose intolerance in people with cystic fibrosis","volume":"111","author":"Nielsen","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0178","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/dc06-1576","article-title":"Microvascular complications in cystic fibrosis-related diabetes","volume":"30","author":"Schwarzenberg","year":"2007","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jcf.2026.03.021_bib0179","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.2337\/dc06-0654","article-title":"Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications","volume":"29","author":"Andersen","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2026.03.021_bib0180","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820966428","article-title":"Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes","volume":"11","author":"Kempegowda","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0181","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcf.2022.03.010","article-title":"Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0182","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nut.2015.10.012","article-title":"Body composition and lung function in cystic fibrosis and their association with adiposity and normal-weight obesity","volume":"32","author":"Alvarez","year":"2016","journal-title":"Nutrition"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0183","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0184","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2019.10.004","article-title":"Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: a single-center analysis","volume":"19","author":"Harindhanavudhi","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcf.2024.09.022","article-title":"Development of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor","volume":"24","author":"Ratti","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.03.021_bib0186","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00174-2023","article-title":"Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study","volume":"62","author":"Frost","year":"2023","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jcf.2026.03.021_bib0187","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jcf.2021.11.008","article-title":"Forewarned is forearmed: the cardiovascular time bomb in Cystic Fibrosis","volume":"21","author":"Duckers","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2026.03.021_bib0188","first-page":"S52","article-title":"Comprehensive medical Evaluation and Assessment of comorbidities: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2026.03.021_bib0189","first-page":"S258","article-title":"Children and Adolescents: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcf.2024.07.018","article-title":"Association of race and ethnicity with the development of cystic fibrosis-related diabetes","volume":"24","author":"Rayas","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2026.03.021_bib0191","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0192","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa2100165","article-title":"Long-term complications in youth-onset type 2 diabetes","volume":"385","author":"Group","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0193","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1089\/dia.2021.0354","article-title":"The effect of Control IQ hybrid closed loop technology on glycemic control in adolescents and adults with cystic fibrosis related diabetes","volume":"24","author":"Scully","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcf.2026.03.021_bib0194","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1016\/S1569-1993(24)01517-0","article-title":"Effect of hybrid closed loop insulin delivery on glycemic control in adolescents and adults with cystic fibrosis-related diabetes","volume":"23","author":"Scully","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/dc23-1411","article-title":"Randomized trial of the insulin-only iLet bionic pancreas for the treatment of cystic fibrosis- related diabetes","volume":"47","author":"Sherwood","year":"2024","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jcf.2026.03.021_bib0196","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jcf.2026.03.021_bib0197","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa167","article-title":"Semaglutide in cystic fibrosis-related diabetes","volume":"105","author":"Gnanapragasam","year":"2020","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.jcf.2026.03.021_bib0198","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcf.2024.08.005","article-title":"Glucagon-like-peptide-1 agonist therapy in adults with cystic fibrosis","volume":"24","author":"Park","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2026.03.021_bib0199","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.aed.2025.03.011","article-title":"Glucagon-like peptide 1 agonist use in an adult with cystic fibrosis-related diabetes and metabolic syndrome","volume":"12","author":"Auth","year":"2025","journal-title":"AACE Endocrinol Diabetes"},{"issue":"9","key":"10.1016\/j.jcf.2026.03.021_bib0200","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1210\/clinem\/dgab365","article-title":"Effect of Sitagliptin on islet function in pancreatic insufficient cystic fibrosis with abnormal glucose tolerance","volume":"106","author":"Kelly","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0201","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/clinem\/dgz102","article-title":"Genetic modifiers of cystic fibrosis-related diabetes have extensive overlap with type 2 diabetes and related traits","volume":"105","author":"Aksit","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2026.03.021_bib0202","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41436-020-01073-x","article-title":"Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth","volume":"23","author":"Lin","year":"2021","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.jcf.2026.03.021_bib0203","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.2337\/db13-1464","article-title":"Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study","volume":"63","author":"Soave","year":"2014","journal-title":"Diabetes"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:46:31Z","timestamp":1781883991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326000883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":201,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1569199326000883"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.021","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research updates in cystic fibrosis related diabetes: Understanding pathophysiology, expanding animal and human islet models, and advancing clinical and translational research","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}